Welcome to our dedicated page for Omada Health SEC filings (Ticker: OMDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omada Health, Inc. (Nasdaq: OMDA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a virtual-first, between-visit healthcare provider focused on cardiometabolic and musculoskeletal conditions, Omada uses these filings to report on its financial condition, operations, and material events related to its digital chronic care platform.
Investors can review current reports on Form 8-K, which Omada uses to furnish press releases announcing quarterly results and other significant developments. For example, recent 8-K filings reference earnings press releases for periods in which the company reported revenue, member growth, and updates on its GLP-1-related offerings and AI capabilities. These current reports help readers connect headline financial and operational metrics to the underlying SEC record.
In addition to 8-Ks, Omada’s periodic reports on Form 10-Q and Form 10-K (accessible through the SEC and linked from this page when available) typically contain more detailed information on revenue composition, cost structure, research and development spending, and risks associated with its virtual care and GLP-1 programs. These filings are particularly relevant for understanding how Omada’s cardiometabolic and musculoskeletal programs, GLP-1 Care Tracks, and prescribing and medication management capabilities are reflected in its financial statements and risk disclosures.
Stock Titan enhances this information with AI-powered summaries that explain key points from lengthy filings, helping readers quickly identify sections related to Omada’s chronic care model, GLP-1 initiatives, and digital health operations. Users can also monitor updates to OMDA’s filings in near real time, including new 8-Ks, 10-Qs, 10-Ks, and other relevant forms, to follow how the company reports on its performance and material events over time.
Omada Health, Inc. (OMDA) is the issuer for a planned sale of its common stock reported by officer Craig Gracey under Rule 144. The notice covers a proposed sale of 644 shares of common stock, with an indicated aggregate market value of $14,283.92, through Morgan Stanley Smith Barney LLC on or after September 9, 2026. The shares relate to 644 restricted stock units with an acquisition date of September 1, 2026. The filing also lists multiple prior 10b5-1 plan sales of Omada common stock by Gracey over the past three months.
Omada Health, Inc. (OMDA) reports that President Shao Wei-Li sold 9,418 shares of common stock on August 12, 2026 at $25.0167 per share in an open-market or private transaction made under a Rule 10b5-1 trading plan adopted on March 13, 2026. After this sale, Shao Wei-Li holds 307,372 shares directly. This amended Form 4 is filed solely to correct the number of shares sold, increasing it by 552 shares that were inadvertently omitted from the original report.
Omada Health, Inc. (OMDA) reported that its President, Wei-Li Shao, disposed of 6,180 shares of common stock on September 1, 2026 as shares were delivered or withheld for payment of exercise price or tax liability. After this transaction, he directly held 301,192 shares of Omada Health common stock.
Omada Health, Inc. (OMDA) reported that Chief Accounting Officer Gracey Craig had 385 shares of common stock withheld or delivered on September 1, 2026, as payment of exercise price or tax liability at $22.84 per share.
After this code F disposition, Craig holds 15,056 shares of Omada Health common stock directly. No Rule 10b5-1 trading plan is indicated for this transaction.
Omada Health, Inc. (OMDA) reported that Chief Financial Officer Steven L. Cook disposed of 4,493 shares of Common Stock on September 1, 2026. The shares were delivered or withheld as payment of exercise price or tax liability at $22.84 per share, leaving him with 182,716 shares held directly. No Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy exercised previously vested stock options and sold shares on September 1, 2026 under a Rule 10b5-1 trading plan adopted on March 13, 2026. He exercised options covering 21,572 shares of common stock at exercise prices of $5.82, $8.28, and $9.18 per share, receiving an equal number of common shares. On the same date he sold a total of 21,572 shares of common stock in market transactions at weighted average prices between roughly $22.69 and $24.56 per share, and an additional 9,885 shares of common stock were delivered or withheld to cover the option exercise price or related tax liability. Following these transactions, an entity associated with him holds 851,659 shares of common stock indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. (OMDA) received a notice under Rule 144 from Sean Duffy indicating an intention to sell up to 21,572 shares of common stock. These shares are to be acquired through the exercise of stock options for cash on 09/01/2026, with Morgan Stanley Smith Barney LLC listed as broker and the stock traded on NASDAQ.
The notice also lists multiple prior Rule 10b5-1 plan sales of Omada common stock by Sean Duffy over the past three months, with individual transactions ranging from a few hundred shares to nearly fifteen thousand shares on specific June–August 2026 dates.
Omada Health, Inc. (OMDA) reported that its Chief Financial Officer, Steven L. Cook, exercised stock options and sold shares on August 27, 2026 under a Rule 10b5-1 trading plan adopted on March 14, 2026. He exercised options for 1,108 shares of common stock at an exercise price of $8.28 per share, then sold 1,108 common shares at $25.00 per share. The option grant was fully vested and exercisable, and following this exercise Cook held 233,481 stock options directly.
Omada Health, Inc. has a significant shareholder group led by Divisadero Street Capital Management, LP and related entities, together with William Zolezzi, reporting beneficial ownership of 3,799,695 shares of common stock, representing 6.3% of the class as of June 30, 2026.
These reporting persons have shared power to vote and dispose of all 3,799,695 shares and no sole voting or dispositive power. All securities are directly owned by advisory clients of Divisadero Street Capital Management, LP, with Divisadero Street Partners, L.P. identified as the only advisory client that may beneficially own more than 5% of the common stock.
American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research report beneficial ownership of Omada Health, Inc. common stock on a Schedule 13G as of June 30, 2026.
The group reports beneficial ownership of 3,678,676 shares, representing 6.2% of the outstanding common stock. They report sole voting power over 3,185,244 shares and sole dispositive power over 3,678,676 shares, with no shared voting or dispositive power. Various advisory clients of American Century Investment Management, Inc. have rights to dividends and sale proceeds, but no single client is indicated as owning more than 5% of the class.